ALK buys shares in a new biotech firm with an experienced leader
20 April 2020
A one-year-old biotech firm can now count one of Denmark’s largest pharmaceutical companies among its owners. ALK hopes the company is sitting on effective allergy treatment.
Key publication for company technology: Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies
27 February 2020
The development of recognition molecules with antibody-like properties is of great value to the biotechnological and bioanalytical communities. The recognition molecules presented here are peptides with a strong tendency to form β-hairpin structures, stabilized by alternate threonines, which are located at one face of the peptide.